CVRX · CVRx, Inc.
$5.09
+0.12 (+2.41%)
At close · Jul 22
Market Cap
$135.07M
Shares
26.54M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$56.65M
+10.4%
FY2025
Net Income
-$53.31M
+11.1%
FY2025
Gross Margin
85.33%
+1.6pp
FY2025
Operating Margin
-90.49%
+25.5pp
FY2025
Diluted EPS
-$2.04
+23%
FY2025
Operating Cash Flow
-$40.17M
-2.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|---|
| $63M – $67M | $59.07M | $56.65M | $51.29M | $39.3M | $22.47M | $13.04M | |
| — | $8.16M | $8.31M | $8.33M | $6.26M | $5M | $3.64M | |
| — | $50.91M | $48.34M | $42.96M | $33.04M | $17.47M | $9.4M | |
| — | — | 85.33% | 83.75% | 84.08% | 77.75% | 72.08% | |
| — | $11.7M | $11.13M | $11.13M | $11.63M | $9.95M | $7.5M | |
| — | $89.2M | $88.47M | $91.32M | $64.51M | $50.05M | $27.86M | |
| — | $100.9M | $99.61M | $102.45M | $76.14M | $60M | $35.36M | |
| — | -$49.99M | -$51.27M | -$59.49M | -$43.1M | -$42.53M | -$25.97M | |
| — | — | -90.49% | -115.98% | -109.69% | -189.27% | -199.2% | |
| — | $5.92M | $5.83M | $4.4M | $1.8M | $165K | $2.22M | |
| — | $3.24M | $3.77M | $3.98M | $3.85M | $1.37M | -$14.8M | |
| — | -$52.67M | -$53.32M | -$59.91M | -$41.05M | -$41.32M | -$42.99M | |
| — | -$12K | -$18K | $55K | $147K | $109K | $91K | |
| — | -$52.66M | -$53.31M | -$59.97M | -$41.2M | -$41.43M | -$43.08M | |
| — | — | -94.1% | -116.91% | -104.85% | -184.38% | -330.45% | |
| — | — | — | — | — | — | -$43.08M | |
| — | -$52.66M | -$53.3M | -$59.96M | -$41.2M | -$41.44M | -$43.09M | |
| USD/shares | — | — | -$2.04 | -$2.65 | -$1.99 | -$2.02 | — |
| USD/shares | — | — | -$2.04 | -$2.65 | -$1.99 | -$2.02 | — |
| shares | — | — | 26.08M | 22.6M | 20.75M | 20.53M | 10.36M |
| shares | — | — | 26.08M | 22.6M | 20.75M | 20.53M | 10.36M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Devices median 2.10×
EV/EBIT
—
Medical Devices median 21.00×
P/E (TTM)
—
Medical Devices median 27.41×
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| United States | $51,883,000 | $47,167,000 | $35,111,000 | $18,021,000 | $9,147,000 | $1,733,000 |
| Germany | $4,768,000 | $4,125,000 | $3,690,000 | $3,477,000 | $3,250,000 | $3,790,000 |
| Other Countries | — | — | $494,000 | $971,000 | $639,000 | $530,000 |